A post-pandemic humoral immune landscape is defined and sustained serological surveillance is supported to identify immunity gaps, anticipate changing infection susceptibility, and strengthen preparedness for future respiratory epidemics.
Abstract
Summary The COVID-19 pandemic profoundly disrupted respiratory pathogen circulation and reshaped population-level humoral immunity. Using a high-throughput pan-respiratory pathogen protein microarray containing 56 antigens, we profiled serum immunoglobulin G (IgG) responses in 287 individuals across pre-pandemic, COVID-19, and post-pandemic periods, as well as validated the findings in an independent cohort of 175 participants. SARS-CoV-2 exposure induced strong cross-reactivity with SARS-CoV but minimal reactivity to MERS-CoV, while variant-specific immunity progressively shifted from pre-Omicron strains toward Omicron lineages. Spike-specific IgG declined over time, whereas nucleocapsid-specific IgG remained relatively stable. Immune responses to common respiratory pathogens were also broadly reorganized, with decreases in human coronaviruses, influenza B, respiratory syncytial viruses, and human parainfluenza viruses, stable influenza A responses, and increased human metapneumovirus-specific IgG. These findings define a post-pandemic humoral immune landscape and support sustained serological surveillance to identify immunity gaps, anticipate changing infection susceptibility, and strengthen preparedness for future respiratory epidemics.
It is demonstrated that post-pandemic sera exhibit enhanced cross-neutralizing antibody responses predominantly against sarbecoviruses, potentially strengthening population immunity against related zoonotic sarbecoviruses and increasing the immunological barrier to their emergence in humans.
Shixiong Zhou, Chunhai Liu, Weiyong Liu et al.· Journal of Infection· 0 citations
Despite the significant impact of SARS-CoV-2 vaccines in curtailing the spread and severity of COVID-19, comprehensive omics-level understanding of longitudinal host responses remains elusive. We recruited 553 Hong Kong participants receiving two doses of CoronaVac (inactivated virus) or BNT162b2 (mRNA-based). Longit...
H. Tun, Shi-Lin Zhao, Chun-Ke Chen et al.· Cellular and Molecular Life...· 0 citations
Substantial inter-individual variation in susceptibility to viral infection persists despite widespread vaccination, and its immunological basis remains poorly understood. We investigated how innate and adaptive immune responses contribute to susceptibility to SARS-CoV-2 infection during the early COVID-19 pandemic. We...
H. Jarras, W. Bazié, I. Blais et al.· medRxiv· 0 citations
Summary Background Long COVID is a heterogeneous condition associated with both early immune responses to SARS-CoV-2 and antibody responses to herpesviruses. However, herpesvirus-directed antibody responses during acute SARS-CoV-2 infection and their relationship to subsequent long COVID remain poorly understood. Metho...
Ananya Choudhury, M. Burry, W. Kwon et al.· EBioMedicine· 0 citations
Overall, natural infection induces a coordinated humoral response biased toward the nucleocapsid antigen, supporting its utility as a marker of recent infection, whereas vaccination elicits a robust multi-subclass antibody response with platform-dependent differences in antigen recognition and subclass distribution.
M. H. Nasraa, D. Abd-Elshafy, Rola Nadeem et al.· Viral immunology· 0 citations
It is hypothesized that next-generation CoV vaccines incorporating highly conserved SARS-CoV-2 T cell antigens would confer potent, broad, long-lasting cross-protective immunity against multiple VOCs.
Swayam Prakash, N. Dhanushkodi, Afshana Quadiri et al.· npj Vaccines· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.